Head-To-Head Comparison: Enovis (NYSE:ENOV) vs. Inspire Medical Systems (NYSE:INSP)

Enovis (NYSE:ENOV) and Inspire Medical Systems (NYSE:INSP) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation.

Valuation & Earnings

This table compares Enovis and Inspire Medical Systems”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.25 billion	0.58	-$1.18 billion	($19.88)	-1.14
Inspire Medical Systems	$915.25 million	1.31	$145.42 million	$4.49	9.23

Inspire Medical Systems has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Enovis has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Enovis and Inspire Medical Systems, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	1	0	7	1	2.89
Inspire Medical Systems	3	13	4	0	2.05

Enovis presently has a consensus target price of $44.50, indicating a potential upside of 96.60%. Inspire Medical Systems has a consensus target price of $81.84, indicating a potential upside of 97.40%. Given Inspire Medical Systems’ higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than Enovis.

Institutional and Insider Ownership

98.5% of Enovis shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 2.9% of Enovis shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Enovis and Inspire Medical Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Enovis	-49.92%	10.32%	4.57%
Inspire Medical Systems	14.33%	10.35%	8.81%

Summary

Inspire Medical Systems beats Enovis on 8 of the 15 factors compared between the two stocks.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

About Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.